Dr. Martens Future Growth
Future criteria checks 0/6
Dr. Martens is forecast to grow earnings and revenue by 3.1% and 5.4% per annum respectively while EPS is expected to grow by 4.5% per annum.
Key information
3.1%
Earnings growth rate
4.5%
EPS growth rate
Luxury earnings growth | 0% |
Revenue growth rate | 5.4% |
Future return on equity | n/a |
Analyst coverage | Good |
Last updated | 12 Jun 2023 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
3/31/2026 | 1,213 | 137 | 123 | 225 | 7 |
3/31/2025 | 1,116 | 116 | 94 | 187 | 7 |
3/31/2024 | 1,038 | 105 | 129 | 225 | 7 |
3/31/2023 | 1,000 | 129 | 26 | 77 | N/A |
12/31/2022 | 979 | 153 | 65 | 108 | N/A |
9/30/2022 | 957 | 177 | 104 | 138 | N/A |
6/30/2022 | 933 | 179 | 132 | 161 | N/A |
3/31/2022 | 908 | 181 | 159 | 184 | N/A |
12/31/2021 | 867 | 118 | 129 | 151 | N/A |
9/30/2021 | 825 | 54 | 98 | 117 | N/A |
6/30/2021 | 799 | 44 | 120 | 138 | N/A |
3/31/2021 | 773 | 35 | 142 | 159 | N/A |
12/31/2020 | 747 | 61 | 156 | 175 | N/A |
9/30/2020 | 722 | 87 | 169 | 190 | N/A |
6/30/2020 | 697 | 81 | 134 | 156 | N/A |
3/31/2020 | 672 | 75 | 100 | 121 | N/A |
3/31/2019 | 454 | 17 | 39 | 56 | N/A |
3/31/2018 | 349 | -6 | 30 | 46 | N/A |
3/31/2017 | 291 | -11 | 26 | 34 | N/A |
3/31/2016 | 232 | -12 | N/A | 26 | N/A |
3/31/2015 | 235 | 0 | N/A | 20 | N/A |
3/31/2014 | 164 | -32 | N/A | 5 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: DOCS N's forecast earnings growth (3.1% per year) is below the savings rate (7.6%).
Earnings vs Market: DOCS N's earnings (3.1% per year) are forecast to grow slower than the MX market (9.2% per year).
High Growth Earnings: DOCS N's earnings are forecast to grow, but not significantly.
Revenue vs Market: DOCS N's revenue (5.4% per year) is forecast to grow slower than the MX market (6.2% per year).
High Growth Revenue: DOCS N's revenue (5.4% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if DOCS N's Return on Equity is forecast to be high in 3 years time